z-logo
open-access-imgOpen Access
T Lymphocytes in Parkinson’s Disease
Author(s) -
Elena Contaldi,
Luca Magistrelli,
Cristoforo Comi
Publication year - 2022
Publication title -
journal of parkinson's disease/journal of parkinson's disease (online)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.747
H-Index - 45
eISSN - 1877-718X
pISSN - 1877-7171
DOI - 10.3233/jpd-223152
Subject(s) - immune system , parkinson's disease , disease , neuroscience , medicine , immunology , central nervous system , biology , pathology
T cells are key mediators of both humoral and cellular adaptive immune responses, and their role in Parkinson’s disease (PD) is being increasingly recognized. Several lines of evidence have highlighted how T cells are involved in both the central nervous system and the periphery, leading to a profound imbalance in the immune network in PD patients. This review discusses the involvement of T cells in both preclinical and clinical studies, their importance as feasible biomarkers of motor and non-motor progression of the disease, and recent therapeutic strategies addressing the modulation of T cell response.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here